Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.

Source:http://linkedlifedata.com/resource/pubmed/id/16098244

Download in:

View as

General Info

PMID
16098244